SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.47-1.1%1:33 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (16912)6/11/2004 5:36:20 PM
From: Bluegreen   of 17367
 
George from my last post>>>>>>>>Although CytoDyn does not control this experimental use of Cytolin, medical records from four doctors shared with the company and submitted to the FDA show that at the end of 1995, they had treated 188 patients with Cytolin for a total of about 700 times for periods up to two years.<<<<<< Do you think these four doctors got sued? Do you think these four doctors and others like them would like to prescribe Raptiva off label? BTW, what about physicians running clinics outside the USA?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext